The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 10, 2019

Filed:

Mar. 11, 2016
Applicant:

MD Healthcare Inc., Seoul, KR;

Inventors:

Yoon-Keun Kim, Namyangju-si, KR;

Bok Yang Pyun, Seoul, KR;

Minhye Kim, Seoul, KR;

Jun-Pyo Choi, Seoul, KR;

Assignee:

MD HEALTHCARE INC., Seoul, KR;

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 35/747 (2015.01); A61K 8/99 (2017.01); A61K 9/00 (2006.01); A61Q 19/00 (2006.01); C12Q 1/689 (2018.01); A61K 35/744 (2015.01); G01N 33/50 (2006.01); A61P 11/00 (2006.01); A61P 29/00 (2006.01); A61P 17/00 (2006.01); A61P 11/06 (2006.01); A61P 11/02 (2006.01);
U.S. Cl.
CPC ...
A61K 35/747 (2013.01); A61K 8/99 (2013.01); A61K 9/007 (2013.01); A61K 35/744 (2013.01); A61P 11/00 (2018.01); A61P 11/02 (2018.01); A61P 11/06 (2018.01); A61P 17/00 (2018.01); A61P 29/00 (2018.01); A61Q 19/00 (2013.01); C12Q 1/689 (2013.01); G01N 33/50 (2013.01); C12Q 2600/118 (2013.01);
Abstract

Provided is a composition for preventing, ameliorating, or treating inflammatory diseases, the composition including, as active ingredients, lactic acid bacteria-derived extracellular vesicles isolated from culture fluid of lactic acid bacteria; and a method for diagnosing atopic dermatitis. The composition including the lactic acid bacteria-derived extracellular vesicles as active ingredients is expected to be usefully used in development of drugs, cosmetics, or health functional food for preventing, ameliorating, or treating inflammatory diseases such as atopic dermatitis, chronic rhinitis, chronic rhinosinusitis, asthma, chronic obstructive pulmonary disease, sepsis, etc. Also, the composition will be usefully used for diagnosis of atopic dermatitis by measuring the distribution of lactic acid bacteria-derived extracellular vesicles in a urine or blood sample.


Find Patent Forward Citations

Loading…